(Q40308558)

English

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.

scientific article published on March 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Alberto Garaventa

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Walentyna Balwierz

11

object named as

Walentyna Balwierz

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Ulrike Pötschger

2

object named as

Ulrike Pötschger

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Maja Beck Popovic

16

object named as

Maja Beck-Popovic

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Ruth Ladenstein

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Andrew D J Pearson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Penelope Brock

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Roberto Luksch

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Victoria Castel

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Isaac Yaniv

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Vassilios Papadakis

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Geneviève Laureys

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Josef Malis

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Ellen Ruud

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Henrik Schroeder

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Ana Forjaz de Lacerda

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Pavel Bician

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Miklós Garami

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Keith Holmes

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Mark Gaze

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Günter Schreier

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Gilles Vassal

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Jean Michon

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

SIOP Europe Neuroblastoma Group (SIOPEN)

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Dominique Valteau-Couanet

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

publication date

2 March 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

500-514

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A multilocus technique for risk evaluation of patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pseudo-observations in survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Resource Utilization and Toxicities After Carboplatin/Etoposide/Melphalan and Busulfan/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative Database

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930070-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(17)30070-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28259608%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40308558&oldid=1953083221"